• Average cost of biopharmaceutical clinical trials per patient U.S. by phase 2013 | Statistic

Health & Pharmaceuticals›
Health System›
Average per-patient biopharmaceutical clinical trial costs in the U.S. 2013, by phase

Premium

Average cost per patient in biopharmaceutical clinical trials in the United States in 2013, by phase
Exclusive Premium Statistic

Average per-patient biopharmaceutical clinical trial costs in the U.S. 2013, by phase

This statistic shows the estimated average per-patient clinical trial costs in the United States in 2013, by phase. That year clinical trials for new medicines for the biopharmaceutical industry cost an average of 36,500 dollars for all phases.

Show more

About this statistic

Show source

Download Settings Share

Chart type

Datalabels

Description Source More information

This statistic shows the estimated average per-patient clinical trial costs in the United States in 2013, by phase. That year clinical trials for new medicines for the biopharmaceutical industry cost an average of 36,500 dollars for all phases.

Show more

Show sources information; Show publisher information
Release date: March 2015

Region: United States
Survey time period: 2013
Supplementary notes: * Because information was not available concerning figures for Phase 0 studies, the source used estimates for Phase IV studies to make an estimate for the very small number of Phase 0 trials.

More information

Other interesting statistics

Total global pharmaceutical R&D spending 2010-2024

Total global pharmaceutical R&D spending 2010-2024

Total global pharmaceutical R&D spending 2010-2024

Research and development expenditure: U.S. pharmaceutical industry 1995-2017

Research and development expenditure: U.S. pharmaceutical industry 1995-2017

Research and development expenditure: U.S. pharmaceutical industry 1995-2017

Leading global contract research organizations based on revenue 2017

Leading global contract research organizations based on revenue 2017

Leading global contract research organizations based on revenue 2017

Industry sectors - expenditure on research and development 2012-2016

Industry sectors - expenditure on research and development 2012-2016

Industry sectors - expenditure on research and development 2012-2016

Research and development in European pharmaceutical industry by country 2016

Research and development in European pharmaceutical industry by country 2016

Research and development in European pharmaceutical industry by country 2016

Statista Accounts: Access All Statistics. Starting from $588 / Year

Prices & Access

Basic Account

Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account

Your perfect start with Statista

Instant access to 1m statistics
Download in XLS, PDF & PNG format
Detailed references

$49 / Month *

Corporate Account

Full access

Corporate solution including all features.

* All products require an annual contract.
Prices do not include sales tax
(New York residents only).

Leading companies trust Statista:

Related Studies: Available to Download in PDF or PPTX Format

Clinical trials

All Information
in one Presentation

Clinical trials

92 page/s
English
pptx
Detailed references

Everything On "Clinical trials" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Clinical trials"

R&D overview

The most important statistics

Total global spending on pharmaceutical research and development from 2010 to 2024 (in billion U.S. dollars)Total global pharmaceutical R&D spending 2010-2024
Percentage of spending on research and development of total revenue from 2012 to 2016, by industrial sector*Industry sectors - expenditure on research and development 2012-2016
Selected top pharmaceutical R&D projects based on net present value (NPV) as of May 2018 (in million U.S. dollars)Top pharmaceutical R&D projects based on net present value May 2018
Research and development expenditure of total U.S. pharmaceutical industry from 1995 to 2017 (in billion U.S. dollars)*Research and development expenditure: U.S. pharmaceutical industry 1995-2017
Pharmaceutical research and development spending in selected European countries in 2016 (in million euros)Research and development in European pharmaceutical industry by country 2016
Total clinical research funding by the National Institutes for Health (NIH) from FY 2013 to FY 2018 (in million U.S. dollars)Total clinical research funding by National Institutes for Health 2013-2018

Top R&D companies

The most important statistics

Global top 10 pharmaceutical companies based on projected R&D spending in 2024 (in billion U.S. dollars)Global top pharmaceutical companies based on R&D spending 2024
World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2016/2017Top 50 global pharmaceutical and biotech companies by R&D intensity in 2016/2017
World's top 50 pharmaceutical and biotechnology companies based on R&D spending growth in 2016/2017Top pharmaceutical companies in R&D spending growth 2016-2017
Number of patients who took part in clinical trials for pharmaceutical company Roche from 2009 to 2017*Roche: participation of patients in clinical trials 2009-2017
Top global contract research organizations (CROs) based on 2017 revenue (in million U.S. dollars)Leading global contract research organizations based on revenue 2017
Investments made by clinical research organizations (CROs) from 2009 to 2014, by phase (in billion U.S. dollars)Investments made by clinical research organizations by phase 2009-2014

Clinical studies

The most important statistics

Complexity of clinical trials compared in 2001-2005 and 2011-2015Comparison between the complexity of clinical trials 2001-2015
Increase in clinical trials' complexity between 2001-2005 and 2011-2015Increase in clinical trials' complexity 2001-2015
Number of registered clinical studies worldwide by location as of August 2017Number of registered clinical studies by location worldwide 2017
Percentage of registered clinical studies worldwide by location as of August 2017Percent of registered clinical studies worldwide by location 2017
Percentage of registered recruiting clinical studies worldwide by location as of August 2017Share of recruiting clinical studies worldwide by location 2017
Total number of registered clinical studies worldwide since 2000 (as of August, 2017)*Total number of registered clinical studies worldwide since 2000
Total number of registered clinical studies with posted results worldwide since 2009 (as of August 2017)*Total number of registered clinical studies with posted results worldwide 2009-2017

Success rates

The most important statistics

Probability of success for drugs in the U.S. in different development phases between 2006 and 2015U.S. drug development Phase success rates 2006-2015
Probability of Phase II success for new drugs in select disease areas in the U.S. between 2006 and 2015U.S. drug development Phase II success rates 2006-2015, by disease area
The probability of Phase III success for new drugs in select disease areas in the U.S. between 2006 and 2015U.S. drug development Phase III success rates from 2006 to 2015, by disease area
Probability of success for oncology vs non-oncology drugs in the U.S. in the different development phases from 2006 to 2015U.S. development Phase success rates for oncology and non oncology drugs 2006-2015
Probability of success for new drugs in the U.S. by development phase between 2006 and 2015, by drug classification U.S. drug development Phase success rates, by drug classification 2006-2015
Probability of success for new drugs in the U.S. with and without selection biomarkers by development phase between 2006 and 2015U.S. development phase success rates for drugs with and without biomarkers 2006-2015

Costs

The most important statistics

Cost of developing a drug in the U.S. from the 1970s until today (in million U.S. dollars)*Pharmaceuticals: cost of drug development in the U.S. since 1975
Phase III R&D costs of projected top orphan drugs as of 2015 (in million U.S. dollars)*Leading orphan drugs based on R&D phase III cost 2015
Average per-study costs by trial phase as of 2014 (in million U.S. dollars)*Average per-study costs by trial phase
Total per-study costs by clinical trial phase and therapeutic area as of 2014 (in million U.S. dollars)Total per-study costs by clinical trial phase and therapeutic area
Clinical trial costs by selected cost component and clinical phase as of 2014 (in U.S. dollars)*Clinical trial costs by select component and phase
Average biopharmaceutical clinical trial cost per patient in the United States in 2013, by selected conditionAverage per-patient clinical trial costs in U.S. 2013, by selected condition
Average cost per patient in biopharmaceutical clinical trials in the United States in 2013, by phaseAverage per-patient biopharmaceutical clinical trial costs in the U.S. 2013, by phase

Approvals, launches, setbacks

The most important statistics

Number of new molecular entities launched in the U.S. from 2003 to 2015Number of new drugs launched in the U.S. 2003-2015
Number of new chemical or biological entities developed between 1992 and 2017, by region of originPharmaceutical industry - number of new substances 1992-2017
Number of first world new molecular entities launched from 2004 to 2015First world new molecular entities launched 2004-2015
Number of first premarket approvals (PMA/HDE) granted by the FDA for medtech products from 2005 to 2017FDA first premarket approvals for medtech products granted 2005-2017
Time from NDA/BLA filings for new drugs to FDA approval in select disease areas in the U.S. between 2006 and 2015NDA/BLA filing to FDA approval times for new drugs in select disease areas 2006-2015
Number of unsuccessful Alzheimer’s drugs in development in the U.S. from 1998 to 2014Number of unsuccessful Alzheimer’s drugs in development in the U.S. 1998-2014
Number of unsuccessful melanoma drugs in development in the United States from 1998 to 2014Unsuccessful developing melanoma drugs in the U.S. 1998-2014
Number of unsuccessful lung cancer drugs in the United States from 1998 to 2014Unsuccessful developing lung cancer drugs in the U.S. 1998-2014

Popular Related Keywords

Need help with using Statista for your research? Tutorials and first steps

Further Content: Statistics, Studies, and Topic Pages

Statistics

Topics

Studies

Statistics on the topic

Topics

About Statista

Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.

Internet & Telecommunications

Consumer Goods & FMCG

Retail & Trade

Travel, Tourism & Hospitality

Society

Transportation & Logistics

Learn more about how Statista can support your business.

Request webinar

Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.

5 News

Latest News

New

New Statista Study: European Football Benchmark

Just in time for the start of the new Premier League season, Statista launches the European Football Benchmark: The first football study that compares the 5 big European leagues from a fan's perspective. Find out everything about the Premier League, its clubs, sponsors and fans.

More Information

New

New tutorial video on the Global Consumer Survey

The Statista Global Consumer Survey offers a global perspective on consumption and media usage, covering the offline and online world of the consumer. The new tutorial video shows all functionalities and illustrates how you can use the DIY analysis tool effectively.

More Information

New

Consumer Electronics Report 2018 out now!

Market reports for the Statista Consumer Market Outlook will now be released roughly every other week starting with the Consumer Electronics Report 2018. The market reports include data as well as qualitative insights into market drivers, consumer behaviour, trends, sales channels and key players.

More Information

Updated

In-depth eMobility Report updated & extended

The trend topic eMobility affects many industries and constantly attracts new players. Our updated in-depth report contains all relevant data and insights and includes an excel file with a detailed list of electric cars, trucks, cargo vehicles, buses, and their specifications.

More Information

Improved

We've given our Market Outlooks a new look

More Information

We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.